Andrew Hyman
Andrew Hyman has made 18 investments in companies such as: BioCryst Pharmaceuticals, Veloxis, Secura Bio, VillageMD, TRIA Beauty, SynCardia Systems, OptiNose, Halozyme Therapeutics, Recro Pharma, Sound Physicians, Agendia, Travere Therapeutics, Apollo Endosurgery, InnoPharma, Clover Health, Progenity, BioFire Diagnostics, Medicrea.
Location of Andrew Hyman is United States.The free version of Angel Match provides limited data for Andrew Hyman. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.
Andrew Hyman is a COO and General Counsel and he his investment types are: Private Equity Firm.
Andrew Hyman focuses investing in industries such as: Biotechnology, Clinical Trials, Therapeutics, Health Care, Pharmaceutical, Genetics, Health Diagnostics, Life Science, Medical, Emergency Medicine, Hospital, Medical Device, Information Technology.
A short brief about investor:
About
Investor type:
Locations:
Past investments
- BioCryst Pharmaceuticals
- Veloxis
- Secura Bio
- VillageMD
- TRIA Beauty
- SynCardia Systems
- OptiNose
- Halozyme Therapeutics
- Recro Pharma
- Sound Physicians
- Agendia
- Travere Therapeutics
- Apollo Endosurgery
- InnoPharma
- Clover Health
- Progenity
- BioFire Diagnostics
- Medicrea